| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Long.term potentiation |
5 genes: RPS6KA6, GRIN2A, ITPR1, RPS6KA2, CACNA1C
|
0.0001032 |
| Neurotrophin signaling pathway |
6 genes: RPS6KA6, IRS1, MAP3K3, RPS6KA2, SORT1, PIK3R3
|
0.0002068 |
| Progesterone.mediated oocyte maturation |
5 genes: ADCY6, RPS6KA6, RPS6KA2, CPEB1, PIK3R3
|
0.000288 |
| Oocyte meiosis |
5 genes: ADCY6, RPS6KA6, ITPR1, RPS6KA2, CPEB1
|
0.0009918 |
| Axon guidance |
5 genes: ARHGEF12, ABLIM1, PLXNA2, NTN4, UNC5C
|
0.001777 |
| Phosphatidylinositol signaling system |
4 genes: PIP5K1C, INPP5A, ITPR1, PIK3R3
|
0.001823 |
| GnRH signaling pathway |
4 genes: ADCY6, ITPR1, MAP3K3, CACNA1C
|
0.004641 |
| Pancreatic secretion |
4 genes: ADCY6, ITPR1, ATP2B4, RAB27B
|
0.004641 |
| mTOR signaling pathway |
3 genes: RPS6KA6, RPS6KA2, PIK3R3
|
0.005009 |
| Calcium signaling pathway |
5 genes: GRIN2A, ITPR1, ATP2B4, CACNA1C, P2RX6
|
0.006635 |
| Vascular smooth muscle contraction |
4 genes: ADCY6, ARHGEF12, ITPR1, CACNA1C
|
0.007542 |
| MAPK signaling pathway |
6 genes: DUSP3, RPS6KA6, MAP3K3, RPS6KA2, CACNA1C, MAP3K13
|
0.009123 |
| Gastric acid secretion |
3 genes: ADCY6, ITPR1, EZR
|
0.01322 |
| Insulin signaling pathway |
4 genes: FOXO1, FLOT2, IRS1, PIK3R3
|
0.01363 |
| Regulation of actin cytoskeleton |
5 genes: DOCK1, ARHGEF12, PIP5K1C, EZR, PIK3R3
|
0.01427 |
| Salivary secretion |
3 genes: ADCY6, ITPR1, ATP2B4
|
0.02156 |
| Pyrimidine metabolism |
3 genes: AK3, TK2, ENTPD1
|
0.0284 |
| Aldosterone.regulated sodium reabsorption |
2 genes: IRS1, PIK3R3
|
0.03178 |
| Vasopressin.regulated water reabsorption |
2 genes: ADCY6, CREB3L2
|
0.03462 |
| Chemokine signaling pathway |
4 genes: ADCY6, GNG7, CXCR5, PIK3R3
|
0.03759 |
| Leukocyte transendothelial migration |
3 genes: CTNND1, EZR, PIK3R3
|
0.04325 |
| Focal adhesion |
4 genes: DOCK1, PIP5K1C, TLN1, PIK3R3
|
0.0447 |
| Lysosome |
3 genes: CLN5, SORT1, CD164
|
0.04699 |